Our strategic possibilities

Efficient contract development and manufacturing offers an attractive solution to bring new products to market; without prohibitive financial risk. Our experience and resources guarantee competitive manufacturing processes and timely market supply. Our skilled staff with experience in cGMP manufacturing is highly motivated to make your product a success.

Focus on innovation

Boehringer Ingelheim Pharma Chemicals takes a flexible approach to the individual needs of pharmaceutical companies that opt to buy rather than make their proprietary new chemical entities (NCEs). Cooperation is undertaken in stages, as desired, and tailored precisely to the customers´ requirements.

Innovative, promising NCEs

We focus on innovation and offer attractive partnerships to pharmaceutical companies in which the generation of intellectual property is their prime source of value creation. Our research-driven partners in this field concentrate on identifying pharmacologically significant targets and developing innovative, promising NCEs. Investments in processes and plant for the large-scale production of NCEs are of secondary importance in their business model.

Customised strategies

Capacity and resource needs

Our development programmes enable us to initiate a partnership tailored to individual requirements. In coordination with our customer and depending on the project, we select a strategy that fits the profile. We offer extensive services in all developmental phases - from development to launch.

Customised service concepts

We offer customised service concepts for our innovation partners. Boehringer Ingelheim Pharma Chemicals´ planning specialists use simulations to minimise risk and to carefully plan capacity and resource needs.

Our outsourcing services:

• custom synthesis
• extraction solutions
• analytical support
• regulatory documentation
• A worldwide sales and logistics network